ID   GBP7_HUMAN              Reviewed;         638 AA.
AC   Q8N8V2;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 2.
DT   28-JUN-2023, entry version 141.
DE   RecName: Full=Guanylate-binding protein 7;
DE            EC=3.6.1.- {ECO:0000250|UniProtKB:Q91Z40};
DE            EC=3.6.5.- {ECO:0000250|UniProtKB:Q91Z40};
DE   AltName: Full=GTP-binding protein 7;
DE            Short=GBP-7;
DE   AltName: Full=Guanine nucleotide-binding protein 7;
DE   AltName: Full=Guanylate-binding protein 4-like;
GN   Name=GBP7; Synonyms=GBP4L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-14.
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=33408175; DOI=10.1128/jvi.02038-20;
RA   Feng M., Zhang Q., Wu W., Chen L., Gu S., Ye Y., Zhong Y., Huang Q.,
RA   Liu S.;
RT   "Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus
RT   Replication by Suppressing Innate Immunity via NF-kappaB and JAK-STAT
RT   Signaling Pathways.";
RL   J. Virol. 95:0-0(2021).
CC   -!- FUNCTION: Interferon (IFN)-inducible GTPase that plays important roles
CC       in innate immunity against a diverse range of bacterial, viral and
CC       protozoan pathogens (By similarity). Hydrolyzes GTP to GMP in two
CC       consecutive cleavage reactions and predominantly uses GTP and not GDP
CC       or GMP as the substrate (By similarity). Following infection, recruited
CC       to the pathogen-containing vacuoles or vacuole-escaped bacteria and
CC       acts as a positive regulator of inflammasome assembly by promoting the
CC       release of inflammasome ligands from bacteria (By similarity). Acts by
CC       promoting lysis of pathogen-containing vacuoles, releasing pathogens
CC       into the cytosol (By similarity). Following pathogen release in the
CC       cytosol, promotes recruitment of proteins that mediate bacterial
CC       cytolysis: this liberates ligands that are detected by inflammasomes,
CC       such as lipopolysaccharide (LPS) that activates the non-canonical
CC       CASP4/CASP11 inflammasome or double-stranded DNA (dsDNA) that activates
CC       the AIM2 inflammasome (By similarity). Also promotes IFN-gamma-mediated
CC       host defense against bacterial infections by regulating oxidative
CC       responses and bacteriolytic peptide generation (By similarity). May
CC       help to assemble NADPH oxidase on phagosomal membranes by acting as a
CC       bridging protein between NADPH oxidase cytosolic subunits NCF2-NCF4 and
CC       the membrane subunits CYBA-CYBB (By similarity). Participates along
CC       with GBP1 in trafficking monoubiquinated protein cargo to autolysosomes
CC       for generating ubiquitin-derived antimicrobial peptides (By
CC       similarity). Facilitates influenza A virus replication by inhibiting
CC       the activation of NF-kappaB and JAK-STAT signaling pathways and the
CC       expression of type I, type III interferons and pro-inflammatory
CC       cytokines (PubMed:33408175). Confers protection to several pathogens,
CC       including the bacterial pathogens Listeria monocytogenes and
CC       Mycobacterium bovis BCG as well as the protozoan pathogen Toxoplasma
CC       gondii (By similarity). Required for disruption of the parasitophorous
CC       vacuole formed following T.gondii infection and subsequent killing of
CC       the parasite (By similarity). {ECO:0000250|UniProtKB:Q91Z40,
CC       ECO:0000269|PubMed:33408175}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000250|UniProtKB:Q91Z40};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670;
CC         Evidence={ECO:0000250|UniProtKB:Q91Z40};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GDP + H2O = GMP + H(+) + phosphate; Xref=Rhea:RHEA:22156,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58115, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000250|UniProtKB:Q91Z40};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22157;
CC         Evidence={ECO:0000250|UniProtKB:Q91Z40};
CC   -!- SUBUNIT: Monomer and dimer (By similarity). Interacts with CYBA, CYBA-
CC       CYBB complex and ATG4B (By similarity). Interacts (via GB1/RHD3-type G
CC       domain) with NCF2 and NCF2-NCF4 complex (By similarity).
CC       {ECO:0000250|UniProtKB:Q91Z40}.
CC   -!- INTERACTION:
CC       Q8N8V2; Q96FN4: CPNE2; NbExp=3; IntAct=EBI-21835810, EBI-7097057;
CC       Q8N8V2; Q96AL5: PBX3; NbExp=3; IntAct=EBI-21835810, EBI-741171;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane
CC       {ECO:0000250|UniProtKB:Q91Z40}.
CC   -!- INDUCTION: Up-regulated in response to influenza virus A infection.
CC       {ECO:0000269|PubMed:33408175}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. GB1/RHD3 GTPase family. GB1 subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU01052}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK096141; BAC04709.1; -; mRNA.
DR   EMBL; AC104459; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS720.1; -.
DR   RefSeq; NP_997281.2; NM_207398.2.
DR   AlphaFoldDB; Q8N8V2; -.
DR   SMR; Q8N8V2; -.
DR   BioGRID; 132790; 12.
DR   IntAct; Q8N8V2; 4.
DR   STRING; 9606.ENSP00000294671; -.
DR   iPTMnet; Q8N8V2; -.
DR   PhosphoSitePlus; Q8N8V2; -.
DR   BioMuta; GBP7; -.
DR   DMDM; 311033384; -.
DR   MassIVE; Q8N8V2; -.
DR   MaxQB; Q8N8V2; -.
DR   PaxDb; Q8N8V2; -.
DR   PeptideAtlas; Q8N8V2; -.
DR   ProteomicsDB; 72463; -.
DR   Antibodypedia; 53266; 62 antibodies from 17 providers.
DR   DNASU; 388646; -.
DR   Ensembl; ENST00000294671.3; ENSP00000294671.2; ENSG00000213512.3.
DR   GeneID; 388646; -.
DR   KEGG; hsa:388646; -.
DR   MANE-Select; ENST00000294671.3; ENSP00000294671.2; NM_207398.3; NP_997281.2.
DR   UCSC; uc001dna.2; human.
DR   AGR; HGNC:29606; -.
DR   CTD; 388646; -.
DR   GeneCards; GBP7; -.
DR   HGNC; HGNC:29606; GBP7.
DR   HPA; ENSG00000213512; Tissue enriched (liver).
DR   MIM; 612468; gene.
DR   neXtProt; NX_Q8N8V2; -.
DR   OpenTargets; ENSG00000213512; -.
DR   PharmGKB; PA142671744; -.
DR   VEuPathDB; HostDB:ENSG00000213512; -.
DR   eggNOG; KOG2037; Eukaryota.
DR   GeneTree; ENSGT00940000164365; -.
DR   HOGENOM; CLU_018608_2_1_1; -.
DR   InParanoid; Q8N8V2; -.
DR   OMA; RENYMKE; -.
DR   OrthoDB; 5309032at2759; -.
DR   PhylomeDB; Q8N8V2; -.
DR   TreeFam; TF331602; -.
DR   PathwayCommons; Q8N8V2; -.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   SignaLink; Q8N8V2; -.
DR   BioGRID-ORCS; 388646; 5 hits in 1135 CRISPR screens.
DR   GenomeRNAi; 388646; -.
DR   Pharos; Q8N8V2; Tbio.
DR   PRO; PR:Q8N8V2; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q8N8V2; protein.
DR   Bgee; ENSG00000213512; Expressed in right lobe of liver and 34 other tissues.
DR   ExpressionAtlas; Q8N8V2; baseline and differential.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISS:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005525; F:GTP binding; ISS:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; ISS:UniProtKB.
DR   GO; GO:0051715; P:cytolysis in another organism; ISS:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; ISS:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IBA:GO_Central.
DR   GO; GO:0042832; P:defense response to protozoan; ISS:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IDA:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0001818; P:negative regulation of cytokine production; IMP:UniProtKB.
DR   GO; GO:0046426; P:negative regulation of receptor signaling pathway via JAK-STAT; IMP:UniProtKB.
DR   GO; GO:0032480; P:negative regulation of type I interferon production; IMP:UniProtKB.
DR   GO; GO:0034345; P:negative regulation of type III interferon production; IMP:UniProtKB.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB.
DR   GO; GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB.
DR   CDD; cd01851; GBP; 1.
DR   CDD; cd16269; GBP_C; 1.
DR   Gene3D; 1.20.1000.10; Guanylate-binding protein, C-terminal domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR030386; G_GB1_RHD3_dom.
DR   InterPro; IPR037684; GBP_C.
DR   InterPro; IPR003191; Guanylate-bd/ATL_C.
DR   InterPro; IPR036543; Guanylate-bd_C_sf.
DR   InterPro; IPR015894; Guanylate-bd_N.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10751; GUANYLATE BINDING PROTEIN; 1.
DR   PANTHER; PTHR10751:SF117; GUANYLATE-BINDING PROTEIN 7; 1.
DR   Pfam; PF02263; GBP; 1.
DR   Pfam; PF02841; GBP_C; 1.
DR   SUPFAM; SSF48340; Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51715; G_GB1_RHD3; 1.
PE   1: Evidence at protein level;
KW   Antimicrobial; Antiviral defense; Cytoplasmic vesicle; GTP-binding;
KW   Hydrolase; Immunity; Innate immunity; Membrane; Nucleotide-binding;
KW   Reference proteome.
FT   CHAIN           1..638
FT                   /note="Guanylate-binding protein 7"
FT                   /id="PRO_0000313654"
FT   DOMAIN          35..277
FT                   /note="GB1/RHD3-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01052"
FT   REGION          1..310
FT                   /note="GTPase domain (Globular)"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   REGION          311..638
FT                   /note="Interaction with the CYBA-CYBB complex"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Z40"
FT   REGION          590..638
FT                   /note="C-terminal tail; required for its localization to
FT                   cytoplasmic vesicle"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Z40"
FT   BINDING         45..52
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Z40"
FT   BINDING         67..69
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   BINDING         97..101
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   VARIANT         14
FT                   /note="T -> I (in dbSNP:rs676913)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_037687"
FT   VARIANT         618
FT                   /note="G -> R (in dbSNP:rs1886297)"
FT                   /id="VAR_037688"
SQ   SEQUENCE   638 AA;  72513 MW;  A9F86253BED61276 CRC64;
     MASEIHMPGP VCLTENTKGH LVVNSEALEI LSAITQPVVV VAIVGLYRTG KSYLMNKLAG
     KNKGFPLGCT VKSETKGIWM WCVPHPSKPN HTLILLDTEG LGDMEKSDPK SDSWIFALAV
     LLSSSFVYNS MGTINHQALE QLHYVTELTE LIRAKSCPRP DEVEDSSEFV SFFPDFIWTV
     RDFTLELKLD GHPITEDEYL ENALKLISGK NPQIQNSNKP REWIRHFFPK QKCFVFDRPI
     NDKKLLLHVE EVREDQLDSN FQMQSENFCS YIFTHAKTKT LREGILVTGN RLGMLVETYL
     DAINSGATPC LENAMAVLAQ CENSAAVQRA ANHYSQQMAQ QVRFPTDTLQ ELLDVHAVCE
     REAIAVFMEY SFKDKSQEFQ KKLVDTMEKK KEDFVLQNEE ASAKYCQAEL KRLSELLTES
     ISRGTFFVPG GHNIYLEAKK KIEQDYTLVP RKGVKADEVL QSFLQSQVVI EESILQSDKA
     LTAGEKAIAA KQAKKEAAEK EQELLRQKQK EQQQMMEAQE RSFQENIAQL KKKMEREREN
     YMRELRKMLS HKMKVLEELL TEGFKEIFES LNEEINRLKE QIEAAENEEP SVFSQILDVA
     GSIFIAALPG AAKLVDLGMK ILSSLCNRLR NPGKKIIS
//
